UNITED STATES PHARMACOPEIAL CONVEN… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1820

Legal Domicile

Principal Officer

RONALD T PIERVINCENZI

Phone

3018810666

Tax Period

2023-07-01 to 2024-06-30

UNITED STATES PHARMACOPEIAL CONVENTION, founded in 1820, is a major nonprofit in the Health Care sector that reported $353.7M in total revenue in fiscal year 2023. Expenses of $330.3M left a modest 7% surplus.

Mission

USP'S MISSION IS TO IMPROVE GLOBAL HEALTH THROUGH PUBLIC STANDARDS AND RELATED PROGRAMS THAT HELP ENSURE THE QUALITY, SAFETY, AND BENEFIT OF MEDICINES AND FOODS.

Program Service Accomplishments

Program 1

Expenses: $190,619,517 Revenue: $302,557,090

COMPENDIAL ACTIVITIES - SEE SCHEDULE O

Program 2

Expenses: $6,692,932 Revenue: $4,829,177

ALLIED COMPENDIAL ACTIVITIES - SEE SCHEDULE O

Program 3

Expenses: $36,319,947 Revenue: $3,896,406

NON-COMPENDIAL ACTIVITIES - SEE SCHEDULE O

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $31,691,692

Program Service Revenue $311,282,673

Investment Income $10,536,524

Other Revenue $238,438

TOTAL REVENUE $353,749,327

Expense Breakdown

Grants Paid $498,078

Salaries & Benefits $177,358,807

Fundraising Expenses $832,128

Program Expenses $233,632,396

Other Expenses $152,480,768

TOTAL EXPENSES $330,337,653

Year-over-Year Comparison

	2023	2022	Change
Revenue	$353,749,327	$346,271,530	+0.0%
Expenses	$330,337,653	$313,280,612	+0.1%
Net Income	$23,411,674	$32,990,918	-0.3%

Key Indicators

✓ Grants to Organizations ✓ Grants to Individuals ✓ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

960

Volunteers

652

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✓ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$3,586,651

Total Directors

Key Employees

$1,970,961

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
DENNIS E DOHERTY MD	CONVENTION PRESIDENT	4.00	Officer Director	$0	$0	$0
TODD K ABRAHAM PHD MBA	TREASURER	4.00	Officer Director	$0	$0	$0
GREGORY E AMIDON PHD	PHARMACEUTICAL SCIENCES TRUSTEE	4.00	Director	$0	$0	$0
GWEN DARIEN	PUBLIC TRUSTEE	4.00	Director	$0	$0	$0
RICHARD J GILFILLAN MD MBA	AT LARGE TRUSTEE	4.00	Director	$0	$0	$0
JESSE L GOODMAN MD MPH	MEDICAL SCIENCES TRUSTEE	4.00	Director	$0	$0	$0
LAURA HERMAN MBA MA	AT LARGE TRUSTEE	4.00	Director	$0	$0	$0
THOMAS MENIGHAN BSPHARMMBA	AT LARGE TRUSTEE	4.00	Director	$0	$0	$0
KRISHNA REDDY NALLAMALLA MD	AT LARGE TRUSTEE	4.00	Director	$0	$0	$0
STEPHEN OSTROFF MD	MEDICAL SCIENCES TRUSTEE	4.00	Director	$0	$0	$0
JULIO SANCHEZ Y TEPOZ MSCSJD	AT LARGE TRUSTEE	4.00	Director	$0	$0	$0
JOHN TAYLOR JD	AT LARGE TRUSTEE	4.00	Director	$0	$0	$0
SUSAN WINCKLER RPH JD	CHAIR AND PHARMA SCI TRUSTEE	4.00	Director	$0	$0	$0
RONALD T PIERVINCENZI	CHIEF EXECUTIVE OFFICER & EX-OFFICIO	38.00	Officer	$1,021,625	$133,537	$1,155,162
ANTHONY P LAKAVAGE	SECRETARY & SVP GLBL EA	38.00	Officer	$509,150	$79,527	$588,677
AMANDA D COWLEY	SVP LEGAL PEOPLE STRATEGY	38.00	Officer	$508,482	$73,873	$582,355
JAKOB VENEMA	EVP & CHIEF SCIENCE OFFICER	38.00	Officer	$609,378	$93,316	$702,694
STANLEY D BURHANS	CHIEF FINANCIAL OFFICER & SVP, OPS	38.00	Officer	$480,371	$77,392	$557,763
JENNIFER DEVINE	SVP, DOC STDS & COMP POLICY	38.00	Key Emp	$408,257	$31,973	$440,230
BRUK ALEMAYEHU	SVP, GLOBAL LAB & TECHNICAL OPS	38.00	Key Emp	$412,396	$48,154	$460,550
VENKAT SURENDRA NATH KODURU	SVP REGIONS & PROGRAM OPS.	38.00	Key Emp	$485,652	$30,194	$515,846
EMILY M KAINE	SVP, GBL HEALTH & MANUFACTURING SVCS	38.00	Key Emp	$507,279	$47,056	$554,335
FOUAD ATOUF	SVP, SCI-GLOB BIO	38.00	Highest	$414,734	$51,329	$466,063
MICHAEL S LEVY	SVP, DIGITAL & INNOVATION	38.00	Highest	$382,355	$43,694	$426,049
KENNETH B ALEXANDER - VP DEP	GC (TO 10/23);VP MNG ATY GLB LG AFF	38.00	Highest	$348,091	$24,069	$372,160
DEBRA J PEREZ	CHIEF EQUITY OFFICER	38.00	Highest	$411,456	$43,987	$455,443
NURISHA R WADE - VP HQS COE	(TO 12/23); VP, INDUSTRY PROGRAMS	38.00	Highest	$347,977	$35,815	$383,792

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	No data	No data	No data	No data
2024	$353,749,327	$330,337,653	$750,835,911	$23,411,674
2023	$346,271,530	$313,280,612	$701,768,432	$32,990,918
2022	$342,334,376	$290,499,670	$655,709,010	$51,834,706
2021	$331,132,598	$285,960,328	$667,918,646	$45,172,270
2020	$318,679,360	$305,692,076	$558,856,219	$12,987,284
2019	$332,879,981	$300,645,416	$541,192,214	$32,234,565

UNITED STATES PHARMACOPEIAL CONVENTION